143 related articles for article (PubMed ID: 33860118)
1. Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD.
Wegermann K; Garrett ME; Zheng J; Coviello A; Moylan CA; Abdelmalek MF; Chow SC; Guy CD; Diehl AM; Ashley-Koch A; Suzuki A
Hepatol Commun; 2021 Apr; 5(4):598-607. PubMed ID: 33860118
[TBL] [Abstract][Full Text] [Related]
2. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
[TBL] [Abstract][Full Text] [Related]
3. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.
Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027
[TBL] [Abstract][Full Text] [Related]
4. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
5. Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables.
Vespasiani-Gentilucci U; Gallo P; Dell'Unto C; Volpentesta M; Antonelli-Incalzi R; Picardi A
World J Gastroenterol; 2018 Nov; 24(43):4835-4845. PubMed ID: 30487694
[TBL] [Abstract][Full Text] [Related]
6. Interaction Between AGTR1 and PPARγ Gene Polymorphisms on the Risk of Nonalcoholic Fatty Liver Disease.
Zhu P; Lu H; Jing Y; Zhou H; Ding Y; Wang J; Guo D; Guo Z; Dong C
Genet Test Mol Biomarkers; 2019 Mar; 23(3):166-175. PubMed ID: 30793973
[TBL] [Abstract][Full Text] [Related]
7. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.
Yang JD; Abdelmalek MF; Pang H; Guy CD; Smith AD; Diehl AM; Suzuki A
Hepatology; 2014 Apr; 59(4):1406-14. PubMed ID: 24123276
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants in nicotinamide-N-methyltransferase (NNMT) gene are related to the stage of non-alcoholic fatty liver disease diagnosed by controlled attenuation parameter (CAP)-fibroscan.
Hasan EM; Abd Al Aziz RA; Sabry D; Darweesh SK; Badary HA; Elsharkawy A; Abouelkhair MM; Yosry A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):265-272. PubMed ID: 30240470
[TBL] [Abstract][Full Text] [Related]
9. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin 2-2 Genotype is Associated with More Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective Study.
Zhou J; Liu J; Sheng H; You N; Chen J; Mi X; Yang W; Zang S; Shi J;
Adv Ther; 2019 Apr; 36(4):880-895. PubMed ID: 30820874
[TBL] [Abstract][Full Text] [Related]
11. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
[TBL] [Abstract][Full Text] [Related]
12. Association of adiponectin gene polymorphisms and additional gene-gene interaction with nonalcoholic fatty liver disease in the Chinese Han population.
Wei Z; Li-Qun Z; Xiao-Ling H; Jian Q; Guo-Yue Y
Hepatol Int; 2016 May; 10(3):511-7. PubMed ID: 26865047
[TBL] [Abstract][Full Text] [Related]
13. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.
Klair JS; Yang JD; Abdelmalek MF; Guy CD; Gill RM; Yates K; Unalp-Arida A; Lavine JE; Clark JM; Diehl AM; Suzuki A;
Hepatology; 2016 Jul; 64(1):85-91. PubMed ID: 26919573
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Nakamura T; Teranishi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A; Hotta K
Hum Genet; 2013 Jul; 132(7):783-92. PubMed ID: 23535911
[TBL] [Abstract][Full Text] [Related]
15. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.
Hamaguchi M; Kojima T; Ohbora A; Takeda N; Fukui M; Kato T
World J Gastroenterol; 2012 Jan; 18(3):237-43. PubMed ID: 22294826
[TBL] [Abstract][Full Text] [Related]
16. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.
Tan HL; Zain SM; Mohamed R; Rampal S; Chin KF; Basu RC; Cheah PL; Mahadeva S; Mohamed Z
J Gastroenterol; 2014 Jun; 49(6):1056-64. PubMed ID: 23800943
[TBL] [Abstract][Full Text] [Related]
17. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP
Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036
[TBL] [Abstract][Full Text] [Related]
18. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.
Yoneda M; Hotta K; Nozaki Y; Endo H; Uchiyama T; Mawatari H; Iida H; Kato S; Fujita K; Takahashi H; Kirikoshi H; Kobayashi N; Inamori M; Abe Y; Kubota K; Saito S; Maeyama S; Wada K; Nakajima A
Liver Int; 2009 Aug; 29(7):1078-85. PubMed ID: 19302184
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
Daijo K; Nakahara T; Inagaki Y; Nanba M; Nishida Y; Uchikawa S; Kodama K; Oya K; Morio K; Fujino H; Ono A; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Hiramatsu A; Hayes CN; Imamura M; Aikata H; Ochi H; Chayama K
J Gastroenterol Hepatol; 2020 Aug; 35(8):1412-1419. PubMed ID: 31896166
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
